Skip to main content
. 2015 Sep 21;6(32):32902–32913. doi: 10.18632/oncotarget.5361

Figure 1. IL13Rα2 overexpression is associated with poor prognosis in resected lung cancer patients.

Figure 1

A. Immunohistochemistry staining of IL13Rα2 in lung cancer and normal lung tissues. Original magnification, × 200. B. Overall survival (OS) and disease-free survival (DFS) curves with IL13Rα2 negative (H score = 0) or positive expression (H score > 0) in resected lung cancer patients. C. OS and DFS curves among resected lung cancer patients with IL13Rα2 weak positive expression (H score 1 to 50) or strong positive expression (H score > 50).